Phase 2 Study for SAR443820 in Participants With Amyotrophic Lateral Sclerosis (ALS)
Public ClinicalTrials.gov record NCT05237284. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAR443820 in Adult Participants With Amyotrophic Lateral Sclerosis, Followed by an Open-label Extension
Study identification
- NCT ID
- NCT05237284
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Sanofi
- Industry
- Enrollment
- 305 participants
Conditions and interventions
Conditions
Interventions
- SAR443820 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 12, 2022
- Primary completion
- Mar 6, 2024
- Completion
- Mar 6, 2024
- Last update posted
- Mar 20, 2025
2022 – 2024
United States locations
- U.S. sites
- 17
- U.S. states
- 11
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UC San Diego Health Site Number : 8400022 | La Jolla | California | 92121 | — |
| USC Site Number : 8400008 | Los Angeles | California | 90033 | — |
| University of California Irvine Site Number : 8400012 | Orange | California | 92868 | — |
| California Pacific Medical Center Site Number : 8400015 | San Francisco | California | 94115 | — |
| University of Colorado Site Number : 8400025 | Aurora | Colorado | 80045 | — |
| Georgetown University Medical Center Site Number : 8400020 | Washington D.C. | District of Columbia | 20007 | — |
| Mayo Clinic Site Number : 8400029 | Jacksonville | Florida | 32224 | — |
| AdventHealth Medical Group - Neurology at Winter Park Site Number : 8400006 | Winter Park | Florida | 32789 | — |
| Northwestern Medical Group, Department of Neurology Site Number : 8400003 | Chicago | Illinois | 60611 | — |
| Johns Hopkins University Site Number : 8400028 | Baltimore | Maryland | 21287 | — |
| Massachusetts General Hospital Site Number : 8400001 | Boston | Massachusetts | 02114 | — |
| Mount Sinai - Union Square Site Number : 8400002 | New York | New York | 10003 | — |
| Penn State Milton S. Hershey Medical Center Site Number : 8400004 | Hershey | Pennsylvania | 17033 | — |
| University of Pennsylvania Site Number : 8400021 | Philadelphia | Pennsylvania | 19104 | — |
| Thomas Jefferson University Hospital Site Number : 8400014 | Philadelphia | Pennsylvania | 19107 | — |
| University of Utah Site Number : 8400009 | Salt Lake City | Utah | 84132 | — |
| Froedtert Hospital & Medical College of Wisconsin Site Number : 8400010 | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 46 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05237284, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 20, 2025 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05237284 live on ClinicalTrials.gov.